HEPATOCELLULAR CARCINOMA RECURRENT
Clinical trials for HEPATOCELLULAR CARCINOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CARCINOMA RECURRENT trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CARCINOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New device offers hope for liver cancer patients out of options
Disease control Recruiting nowThis study tests a device called TheraBionic P1 in people with advanced liver cancer who have already tried at least two other treatments or cannot take standard therapy. The goal is to see if the device can help them live longer and improve their quality of life. About 198 adult…
Matched conditions: HEPATOCELLULAR CARCINOMA RECURRENT
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for liver transplant patients with recurrent cancer: immunotherapy combo under study
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of two drugs, atezolizumab and bevacizumab, can safely treat liver cancer that has come back after a liver transplant. The study includes 50 patients who will receive the drug combo every three weeks along with a strict immunosu…
Matched conditions: HEPATOCELLULAR CARCINOMA RECURRENT
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC